Anixa Biosciences, Inc. (FRA:CY71)
Germany
· Delayed Price · Currency is EUR 4.100
+0.040 (0.99%)
At close: Dec 4, 2025
Anixa Biosciences Employees
Anixa Biosciences had 5 employees as of October 31, 2024. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
€1,943,347
Market Cap
135.53M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 318,000 |
| Allianz SE | 156,626 |
| Deutsche Telekom AG | 198,194 |
| Siemens Energy AG | 103,000 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Rheinmetall AG | 28,539 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Anixa Biosciences News
- 18 days ago - Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript - Seeking Alpha
- 18 days ago - Anixa Biosciences (ANIX) Unveils New Name for Ovarian Cancer Therapy - GuruFocus
- 18 days ago - Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization - PRNewsWire
- 23 days ago - Anixa Biosciences: Hard To Justify The Market's Optimism With An Upcoming Phase 1 Readout - Seeking Alpha
- 23 days ago - Water Tower Research Issues Statement Regarding Technical Interruption During Anixa Biosciences Fireside Chat - GlobeNewsWire
- 23 days ago - Anixa Biosciences (ANIX) Secures U.S. Patent for Breast Cancer Vaccine - GuruFocus
- 23 days ago - Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s - PRNewsWire
- 25 days ago - Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025 - PRNewsWire